Inari Medical, Inc. (NASDAQ:NARI – Get Rating) saw a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 2,190,000 shares, a growth of 25.1% from the February 28th total of 1,750,000 shares. Approximately 5.0% of the company’s stock are short sold. Based on an average […]
Bank of America began coverage on shares of Inari Medical (NASDAQ:NARI – Get Rating) in a research note issued to investors on Wednesday, The Fly reports. The brokerage set a “buy” rating on the stock. NARI has been the topic of a number of other reports. Canaccord Genuity Group reduced their target price on shares […]
Inari Medical (NASDAQ:NARI – Get Rating) had its target price cut by Canaccord Genuity Group from $102.00 to $96.00 in a research note published on Monday morning, The Fly reports. Other equities research analysts also recently issued research reports about the company. Canaccord Genuity Group decreased their price target on Inari Medical from $102.00 to […]
Inari Medical, Inc. (NASDAQ:NARI – Get Rating) CEO William Hoffman sold 60,000 shares of the stock in a transaction on Monday, March 7th. The shares were sold at an average price of $95.48, for a total transaction of $5,728,800.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through […]